Filter
1324
Filtered Results: 1324
Text search:
co-morbidities
Featured
Recommendations
146
New Publications
236
Language
Document type
No document type
556
Guidelines
302
Studies & Reports
257
Strategic & Response Plan
62
Manuals
60
Fact sheets
45
Situation Updates
15
Training Material
13
Infographics
8
Resource Platforms
4
Brochures
1
Online Courses
1
Countries / Regions
Global
89
India
80
South Africa
42
Kenya
38
Latin America and the Carribbean
38
Western and Central Europe
32
Africa
27
Ethiopia
22
Nigeria
20
Bangladesh
18
Eastern Europe
17
Brazil
17
Uganda
15
Ghana
14
South–East Asia Region
14
Ukraine
12
Rwanda
12
Nepal
11
Philippines
10
Tanzania
10
East and Southern Africa
10
Myanmar / Burma
10
Sierra Leone
9
Syria
9
Malawi
9
Asia
9
Germany
9
West and Central Africa
9
Middle East and North Africa
9
Namibia
9
Zambia
9
Senegal
8
Congo, Democratic Republic of
8
Russia
8
Indonesia
8
Zimbabwe
7
Eswatini/ Swaziland
6
Cameroon
5
Burkina Faso
5
Peru
5
Mozambique
5
Western Pacific Region
5
South Sudan
5
Colombia
4
Chile
4
Eastern Europe and Central Asia
4
United Kingdom
4
Liberia
4
Lesotho
3
Cambodia
3
Vietnam
3
Georgia
3
Angola
3
Pakistan
3
Tajikistan
2
Turkey
2
Benin
2
Togo
2
Laos
2
Guinea
2
Venezuela
2
North America
2
Portugal
2
Bolivia
2
Argentina
2
Egypt
2
Botswana
2
Somalia
2
Ecuador
2
Madagascar
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Mexico
1
Gambia
1
Singapore
1
Estonia
1
Afghanistan
1
Burundi
1
USA
1
Haiti
1
Guinea-Bissau
1
Paraguay
1
Gabon
1
Jamaica
1
France
1
Mauritius
1
Spain
1
Algeria
1
Southern Africa
1
Moldova
1
Romania
1
Central African Republic
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
482
Clinical Guidelines
167
Public Health
97
Women & Child Health
30
Key Resources
13
Capacity Building
10
Pharmacy & Technologies
2
Toolboxes
COVID-19
280
TB
156
HIV
142
Mental Health
123
NCDs
83
Caregiver
36
AMR
30
NTDs
28
Disability
23
Rapid Response
20
Pharmacy
17
Conflict
17
Refugee
14
Planetary Health
10
Health Financing Toolbox
8
Ebola
7
Cholera
6
Global Health Education
6
Natural Hazards
3
Polio
3
Zika
2
Specific Hazards
1
Social Ethics
1
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The response to a cholera outbreak must focus on limiting mortality and reducing the spread of the disease. It should be comprehensive and multisectoral, including epidemiology, case management, water, sanitation and hygiene, logistics, community engagement and risk communication. All efforts must b...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
Background
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.
Methods
This review is based on articles retrieved by a selective search in PubMed, as well as on r...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
